TrialJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2010

A phase II study of sorafenib in malignant mesothelioma: results of Cancer and Leukemia Group B 30307.

Sarita Dubey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.